The Company has informed that at the meeting of the Board of Directors of the Company held on March 17, 2004, considered the proposal of amalgamation of Burroughs Wellcome India Ltd with the company and approved the same. The Board has decided that subject to receipt of the necessary approvals, the company will issue and allot at par to the shareholders of Burroughs Wellcome India Ltd, 14 equity shares of Rs 10 each, credited as fully paid up in the capital of the company for every 10 equity shares of Rs 10 each held by such shareholder in Burroughs Wellcome India Ltd. Glaxosmithkline Pharmaceuticals Limited has informed the Exchange that the Hon'ble High Court of Bombay has approved the Scheme of Amalgamation of Burroughs Wellcome (India) Ltd. with the company. The BOD of the company at its meeting held on September 15, 2004 has fixed Record date as October 11, 2004 for the purpose of ascertaining the names of shareholders of Burroughs Wellcome (India), who will be entitled to receive 14 equity shares of face value 10/- per share of Glaxosmithkline Pharmaceuticals Ltd. for every 10 equity shares of face value Rs.10/-each held by them in Burroughs Wellcome (India) Ltd. (As per NSE Bulletin dated on 28/09/2004) Members of the Exchange are hereby informed that the under mentioned new securities of GlaxoSmithKline Pharmaceuticals Limited (Scrip Code: 500660; ISIN No. INE159A01016), are listed and permitted for trading on the Exchange with effect from Friday, the 10th December 2004. Securities 1,28,47,546*Equity Shares of Rs.10/- each (fully paid-up) issued to shareholders of erstwhile Burroughs Wellcome (India) Limited pursuant to the Scheme of Amalgamation of the company. Dist. Nos. 7,44,75,001 to 8,73,22,546 * These shares are ranking pari-passu with the old equity shares of the company. 2. The brief particulars of the Scheme of Amalgamation are as mentioned below: a) The Scheme of Amalgamation of the company was approved by the Hon'ble High Court of Bombay vide its order dated 12th August 2004. b) The appointed date: 1st January, 2004 c) Date of Allotment: 29th October, 2004 d) Exchange Ratio - For every 10 Equity Shares of Rs.10/- each held in erstwhile Burroughs Wellcome (India) Limited, 14 Equity Share of Rs.10/- each of the company have been issued. 3. As per Exchange Notice No.20040927-10 dated 27th September 2004, the transferor company viz. Burroughs Wellcome (India) Limited, had fixed 11th October 2004 as 'Record Date', for giving effect to the Scheme of Amalgamation and accordingly dealing in the abovementioned securities of the transferor company was stopped with effect from 4th October 2004. 4. The company's financial year ends on 31st December. (As per BSE Notice dated on 09/12/2004)